UAL
80
-3
JNJ
42
-2
XOM
42
5
KMI
69
4
MRK
25
2
AAL
48
6
COST
50
2
FCX
65
6
L
47
-5
RSG
60
3
HST
58
11
MHK
43
4
HPQ
52
3
PYPL
41
2
NI
60
2
DVN
43
7
EXPE
74
2
OMC
59
4
LNC
39
-6
XRX
30
2
UAL
80
-3
JNJ
42
-2
XOM
42
5
KMI
69
4
MRK
25
2
AAL
48
6
COST
50
2
FCX
65
6
L
47
-5
RSG
60
3
HST
58
11
MHK
43
4
HPQ
52
3
PYPL
41
2
NI
60
2
DVN
43
7
EXPE
74
2
OMC
59
4
LNC
39
-6
XRX
30
2
Financhill
Back

US Physical Therapy 10K Form

Sell
45

USPH
US Physical Therapy

Last Price:
82.65
Seasonality Move:
8.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive USPH News And Ratings

See the #1 stock for the next 7 days that we like better than USPH

USPH Financial Statistics

Sales & Book Value

Annual Sales: $604.8M
Cash Flow: $26.66M
Price / Cash Flow: 18.38
Annual Sales: $32.14
Price / Book: 2.58

Profitability

EPS (TTM): 1.82000
Net Income (TTM): $12.58M
Gross Margin: $121.51M
Return on Equity: 1.9%
Return on Assets: 1.25%

US Physical Therapy Earnings Forecast

Key US Physical Therapy Financial Ratios

  • The Gross Profit Margin over the past 33 years for USPH is 20.09%.
  • The Selling, General & Administrative Expenses for USPH have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 63.40% of Operating Income.
  • The Net Earning history of USPH is 2.43% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

US Physical Therapy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: USPH
CUSIP: 90337L
Website: usph.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 1.88
Quick Ratio: 1.77

Price-to-Earnings

Trailing P/E Ratio: 64.69
Forward P/E Ratio: 28.3

USPH Technical Analysis vs Fundamental Analysis

Sell
45
US Physical Therapy (USPH) is a Sell

Is US Physical Therapy a Buy or a Sell?